ArticleBlood cancer journal2024

Momelotinib for myelofibrosis: our 14 years of experience with 100 clinical trial patients and recent FDA approval.

Ayalew Tefferi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.